| P50 | author | Abd A. Tahrani | Q38362198 |
| P2093 | author name string | A H Barnett | |
| | Q-A Altaf | |
| P2860 | cites work | Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 |
| | Impact of sleep debt on metabolic and endocrine function | Q23731787 |
| | Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss | Q23919884 |
| | Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study | Q24652963 |
| | Adverse metabolic and cardiovascular consequences of circadian misalignment | Q24656239 |
| | Melatonin secretion and the incidence of type 2 diabetes | Q27277216 |
| | Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance | Q28186874 |
| | FXR is a molecular target for the effects of vertical sleeve gastrectomy | Q28236848 |
| | Potential role and therapeutic interests of myo-inositol in metabolic diseases | Q28292692 |
| | Apelin stimulates glucose utilization in normal and obese insulin-resistant mice | Q28302298 |
| | Partial sleep restriction decreases insulin sensitivity in type 1 diabetes | Q28396396 |
| | The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity | Q28506782 |
| | Disruption of the Circadian Clock in Mice Increases Intestinal Permeability and Promotes Alcohol-Induced Hepatic Pathology and Inflammation | Q28534128 |
| | Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling | Q28581883 |
| | The lipid phosphatase SHIP2 controls insulin sensitivity | Q28584843 |
| | Obesity, gut hormones, and bariatric surgery. | Q37511828 |
| | Metabolism and circadian rhythms--implications for obesity | Q37621141 |
| | Bariatric surgery and taste: novel mechanisms of weight loss. | Q37630305 |
| | Glycaemic control in type 2 diabetes: targets and new therapies | Q37636745 |
| | Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. | Q37638200 |
| | Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications. | Q37695713 |
| | The beta-cell in human type 2 diabetes. | Q37706253 |
| | Aerobic exercise and weight loss reduce vascular markers of inflammation and improve insulin sensitivity in obese women | Q37707072 |
| | Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease | Q37742798 |
| | Management of type 2 diabetes: new and future developments in treatment | Q37894446 |
| | 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders? | Q38015005 |
| | Mechanisms of weight loss, diabetes control and changes in food choices after gastrointestinal surgery. | Q38045816 |
| | Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins | Q45050580 |
| | Sibutramine improves fat distribution and insulin resistance, and increases serum adiponectin levels in Korean obese nondiabetic premenopausal women. | Q45162841 |
| | Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea | Q45287871 |
| | Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. | Q45917277 |
| | Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion | Q46116312 |
| | Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics | Q46155945 |
| | Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. | Q46168291 |
| | Effect of vanadium on insulin sensitivity in patients with impaired glucose tolerance. | Q46228724 |
| | Metabolic risk factors in formerly obese women--effects of a pronounced weight loss by gastric band operation compared with weight loss by diet alone | Q46422658 |
| | Diabetes-induced renal vascular dysfunction is normalized by inhibition of epidermal growth factor receptor tyrosine kinase. | Q46508745 |
| | Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes | Q46731741 |
| | Autonomic nervous system activity in diabetic and healthy obese female subjects and the effect of distinct weight loss strategies. | Q46766572 |
| | The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). | Q46878587 |
| | Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats | Q46910051 |
| | Efficacy, safety and tolerability of tesaglitazar when added to the therapeutic regimen of poorly controlled insulin-treated patients with type 2 diabetes | Q46973474 |
| | The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes | Q47983895 |
| | U-shaped association of sleep duration with metabolic syndrome and insulin resistance in patients with type 2 diabetes: the Fukuoka Diabetes Registry | Q48132336 |
| | Sleep apnoea syndrome and 10-year cardiovascular risk in females with type 2 diabetes: relationship with insulin secretion and insulin resistance | Q48202771 |
| | Associations of chronotype and sleep with cardiovascular diseases and type 2 diabetes | Q48202905 |
| | Sleep apnea and glucose metabolism: a long-term follow-up in a community-based sample | Q48249427 |
| | Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome in nonobese adults | Q48297395 |
| | Increasing length of wakefulness and modulation of hypocretin-1 in the wake-consolidated squirrel monkey | Q48460311 |
| | Estimating cardiac autonomic activity during sleep: impedance cardiography, spectral analysis, and Poincaré plots | Q48606202 |
| | Effect of sleep deprivation on overall 24 h growth-hormone secretion | Q48710927 |
| | Effects of insufficient sleep on blood pressure in hypertensive patients: a 24-h study | Q48770123 |
| | Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study | Q50546299 |
| | Long-term longitudinal study on the relationship between alternating shift work and the onset of diabetes mellitus in male Japanese workers. | Q50781903 |
| | Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial. | Q51352550 |
| | Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes. | Q51369967 |
| | Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. | Q51581413 |
| | Effects of D-chiroinositol added to a meal on plasma glucose and insulin in hyperinsulinemic rhesus monkeys. | Q54158115 |
| | Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. | Q54606528 |
| | Discovery of a Small Molecule Insulin Mimetic with Antidiabetic Activity in Mice | Q58449888 |
| | Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women | Q28741820 |
| | Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery | Q29614192 |
| | Mechanisms linking obesity to insulin resistance and type 2 diabetes | Q29614887 |
| | Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study | Q29615122 |
| | Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite | Q29615447 |
| | Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin | Q29616274 |
| | The pathobiology of diabetic complications: a unifying mechanism | Q29617766 |
| | Circadian integration of metabolism and energetics | Q29619638 |
| | Mechanisms for insulin resistance: common threads and missing links | Q29620447 |
| | New advances in models and strategies for developing anti-obesity drugs | Q30429816 |
| | Obstructive sleep apnea in young lean men: impact on insulin sensitivity and secretion | Q30447694 |
| | Role of sleep and sleep loss in hormonal release and metabolism | Q30476176 |
| | Bariatric surgery: a systematic review and meta-analysis | Q30769299 |
| | Discovery of a small molecule insulin receptor activator | Q32120094 |
| | Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans | Q32774312 |
| | Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes | Q33746480 |
| | Circadian control of glucose metabolism. | Q33766028 |
| | PTEN mutations as a cause of constitutive insulin sensitivity and obesity. | Q33811688 |
| | Sleep deprivation effects on the activity of the hypothalamic-pituitary-adrenal and growth axes: potential clinical implications | Q33872668 |
| | Activation of protein kinase C isoforms and its impact on diabetic complications | Q33881442 |
| | Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity. | Q33928649 |
| | The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy | Q33932723 |
| | Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade | Q33942025 |
| | The effects of extended bedtimes on sleep duration and food desire in overweight young adults: a home-based intervention | Q33956326 |
| | Insulin resistance and cardiovascular disease | Q34011027 |
| | Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects | Q34033254 |
| | Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase | Q34084865 |
| | Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer | Q34087341 |
| | Epidemiology of obstructive sleep apnea: a population health perspective | Q34126856 |
| | Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy | Q34129374 |
| | Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis | Q34192476 |
| | The impact of effective continuous positive airway pressure on homeostasis model assessment insulin resistance in non-diabetic patients with moderate to severe obstructive sleep apnea | Q34227968 |
| | Bariatric surgery versus conventional medical therapy for type 2 diabetes | Q34263754 |
| | 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors still improve metabolic phenotype in male 11β-HSD1 knockout mice suggesting off-target mechanisms | Q34316507 |
| | Meta-analysis: continuous positive airway pressure improves insulin resistance in patients with sleep apnea without diabetes | Q34340704 |
| | Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus | Q34461583 |
| | Role of leptin and adiponectin in insulin resistance | Q38069779 |
| | Non-peptidyl insulin mimetics as a potential antidiabetic agent | Q38100566 |
| | 11β-HSD1 inhibitors for the treatment of type 2 diabetes and cardiovascular disease | Q38132710 |
| | Cellular and molecular mechanisms of endothelial dysfunction in diabetes | Q38134022 |
| | Obstructive sleep apnoea and diabetes: an update | Q38139184 |
| | SIRT1 metabolic actions: Integrating recent advances from mouse models | Q38190964 |
| | Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes | Q38195883 |
| | Circadian rhythms, insulin action, and glucose homeostasis | Q38210370 |
| | Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice | Q38290824 |
| | Rimonabant ameliorates insulin resistance via both adiponectin-dependent and adiponectin-independent pathways | Q38359027 |
| | Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice | Q38359290 |
| | Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial | Q38392749 |
| | Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications | Q38428629 |
| | High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men. | Q38443882 |
| | Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial | Q38494463 |
| | Global estimates of diabetes prevalence for 2013 and projections for 2035. | Q39231145 |
| | The relationship between breakfast skipping, chronotype, and glycemic control in type 2 diabetes | Q39339317 |
| | A novel hydroxyfuroic acid compound as an insulin receptor activator. Structure and activity relationship of a prenylindole moiety to insulin receptor activation | Q39535230 |
| | The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. | Q39735999 |
| | Effect of continuous positive airway pressure therapy on cardiovascular risk factors in patients with type 2 diabetes and obstructive sleep apnea. | Q40061787 |
| | Signaling Effects of Demethylasterriquinone B1, a Selective Insulin Receptor Modulator | Q40648668 |
| | Activation of insulin signal transduction pathway and anti-diabetic activity of small molecule insulin receptor activators | Q40750338 |
| | Insulin-like effect of pinitol | Q40859886 |
| | Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass | Q42449157 |
| | Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes | Q42764571 |
| | Effects of one year treatment of sibutramine on insulin resistance parameters in type 2 diabetic patients. | Q42796380 |
| | A novel IKKbeta inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance | Q42825735 |
| | A novel small molecule that directly sensitizes the insulin receptor in vitro and in vivo | Q42830170 |
| | Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice | Q42833043 |
| | Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects | Q43270770 |
| | Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux-en-Y gastric bypass--a randomized controlled trial | Q43474000 |
| | Intensive lifestyle changes are necessary to improve insulin sensitivity: a randomized controlled trial | Q43903128 |
| | The impact of sleep apnea treatment on carbohydrate metabolism in patients with acromegaly. | Q44125240 |
| | Improvement in hepatic insulin sensitivity after Roux-en-Y gastric bypass in a rat model of obesity is partially mediated via hypothalamic insulin action | Q44218851 |
| | Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice | Q44219623 |
| | Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. | Q44273298 |
| | Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity | Q44547601 |
| | Effects of vanadium (III, IV, V)-chlorodipicolinate on glycolysis and antioxidant status in the liver of STZ-induced diabetic rats | Q44591196 |
| | Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease | Q44699316 |
| | Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes | Q44705123 |
| | Obstructive sleep apnoea and the risk of type 2 diabetes: a meta-analysis of prospective cohort studies | Q44797062 |
| | Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines | Q44883229 |
| | PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome | Q34566145 |
| | Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial | Q34660831 |
| | A single night of sleep deprivation increases ghrelin levels and feelings of hunger in normal-weight healthy men. | Q34787461 |
| | Protein kinase C inhibition ameliorates functional endothelial insulin resistance and vascular smooth muscle cell hypersensitivity to insulin in diabetic hypertensive rats | Q35081129 |
| | Apelin and insulin resistance: another arrow for the quiver? | Q35166911 |
| | Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated? | Q35981002 |
| | Bariatric surgery versus intensive medical therapy in obese patients with diabetes | Q36025669 |
| | Type 2 diabetes: principles of pathogenesis and therapy | Q36095054 |
| | Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. | Q36287612 |
| | Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance | Q36392797 |
| | Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease | Q36563015 |
| | The twentieth century struggle to decipher insulin signalling | Q36631664 |
| | Role of insulin resistance in endothelial dysfunction | Q36674069 |
| | High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. | Q36720635 |
| | Treating insulin resistance: future prospects. | Q36806514 |
| | Pilot study of resveratrol in older adults with impaired glucose tolerance. | Q36895103 |
| | 11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects | Q36967015 |
| | Modulation of glucocorticoid action and the treatment of type-2 diabetes | Q37022376 |
| | Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment | Q37022586 |
| | PTP1B and TC-PTP: regulators of transformation and tumorigenesis | Q37072449 |
| | Diagnosis of obstructive sleep apnea in adults | Q37077144 |
| | Chronotype is independently associated with glycemic control in type 2 diabetes | Q37106369 |
| | Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell Function in type 2 diabetic patients | Q37110587 |
| | Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 |
| | Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial | Q37151277 |
| | Short sleep duration measured by wrist actimetry is associated with deteriorated glycemic control in type 1 diabetes | Q37193527 |
| | Genetic dissection of type 2 diabetes | Q37322800 |
| | 11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle | Q37400786 |
| | Reduced sleep duration or quality: relationships with insulin resistance and type 2 diabetes | Q37403202 |
| | Role of resistin in insulin sensitivity in rodents and humans | Q37411522 |
| | Effects of Roux-en-Y gastric bypass or diabetes support and education on insulin sensitivity and insulin secretion in morbidly obese patients with type 2 diabetes | Q37445774 |
| | Association of obstructive sleep apnea in rapid eye movement sleep with reduced glycemic control in type 2 diabetes: therapeutic implications | Q37504129 |
| P433 | issue | 4 | |
| P921 | main subject | insulin resistance | Q1053470 |
| | type 2 diabetes | Q3025883 |
| P304 | page(s) | 319-334 | |
| P577 | publication date | 2014-11-12 | |
| P1433 | published in | Diabetes, Obesity and Metabolism | Q5270109 |
| P1476 | title | Novel therapeutics for type 2 diabetes: insulin resistance | |
| P478 | volume | 17 | |